|
1. Biologie
|
|
|
|
|
3.7 Prévention - Alcool
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
|
5.12.9 Immunothérapies - SITC
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
FDA approves the first pill that can alert your doctor when you swallow it [STAT]
|
|
|
|
|
|
The
new product, which will be sold as Abilify MyCite, can be swallowed
just like any other pill. When that happens, the ingestible sensor
inside it sends a message to a patch worn by the patient, which then
transmits the information to a mobile app that the patient can monitor.
If a patient opts to allow it, the patient’s caregivers and doctor can
access the data online, too.
|
|
|
|
|
|
|
EMA Recommends Approval of Biosimilar Bevacizumab [ESMO]
|
|
|
|
|
|
Mvasi
is a biosimilar medicinal product. It is highly similar to the
reference product Avastin (bevacizumab), which was authorised in the EU
on 12 January 2015. Data show that Mvasi has comparable quality, safety
and efficacy to Avastin.
|
|
|
|
|
|
|
|
|
5.8.4 ASH - CAR T
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.11 Patients
|
|
|
Why do some women refuse treatments for their breast cancer? [Science-Based Medicine]
|
|
|
|
|
|
Adjuvant
therapy after surgery, such as chemotherapy, hormonal therapy, and
radiation therapy, has contributed to a 39% decrease in breast cancer
mortality since 1989. Unfortunately, a significant number of women
decline evidence-based adjuvant therapy. A recent study suggests that
distrust of the medical system plays a significant role in such refusal.
|
|
|
|
|
|
|
6.7.1 Bioinformatique
|
|
|
|
6.7.2 Applis
|
|
|
Matt Morgan: WhatsApp Doc? [BMJ Blogs]
|
|
|
|
|
|
In
my day job, I use fax machines, Windows 98, 1980s pagers, and
landlines. As I cross the hospital exit, I use mobile data, WhatsApp,
secure banking apps, and iPads.
|
|
|
|
|
|
|
6.7.3 DMP
|
|
|